Scopolammonium, N-methylbromide en es it fr

Scopolammonium, N-methylbromide Brand names, Scopolammonium, N-methylbromide Analogs

Scopolammonium, N-methylbromide Brand Names Mixture

  • Biosol-M-Aquadrops liq (methscopolamine bromide + neomycin sulfate)
  • Neomix-pamine Scour Bolus (methscopolamine bromide + neomycin sulfate)
  • Neomix-pamine Solution (methscopolamine bromide + neomycin sulfate)
  • Neosol M Aquadrops (methscopolamine bromide + neomycin)
  • Scour solution (methscopolamine bromide + neomycin)
  • Scour solution coop (methscopolamine bromide + neomycin)

Scopolammonium, N-methylbromide Chemical_Formula

C18H24NO4.Br

Scopolammonium, N-methylbromide RX_link

http://www.rxlist.com/cgi/pharmclips2.cgi?keyword=%20Methscopolamine

Scopolammonium, N-methylbromide fda sheet

Scopolammonium,_N-methylbromide FDA

Scopolammonium, N-methylbromide msds (material safety sheet)

Scopolammonium, N-methylbromide Synthesis Reference

No information avaliable

Scopolammonium, N-methylbromide Molecular Weight

397.089 g/mol

Scopolammonium, N-methylbromide Melting Point

225 oC

Scopolammonium, N-methylbromide H2O Solubility

Freely soluble

Scopolammonium, N-methylbromide State

Solid

Scopolammonium, N-methylbromide LogP

-2.58

Scopolammonium, N-methylbromide Dosage Forms

Tablet (2.5mg, 5mg)

Scopolammonium, N-methylbromide Indication

Used as adjunctive therapy for the treatment of peptic ulcer. Also used to treat nausea and vomiting due to motion sickness.

Scopolammonium, N-methylbromide Pharmacology

Methscopolamine bromide is a muscarinic antagonist structurally similar to the neurotransmitter acetylcholine and acts by blocking the muscarinic acetylcholine receptors and is thus classified as an anticholinergic. Methscopolamine bromide has many uses including the prevention of motion sickness. It is not clear how methscopolamine bromide prevents nausea and vomiting due to motion sickness. The vestibular part of the ear is very important for balance. When a person becomes disoriented due to motion, the vestibule sends a signal through nerves to the vomiting center in the brain, and vomiting occurs. Acetylcholine is a chemical that nerves use to transmit messages to each other. It is believe that methscopolamine bromide prevents communication between the nerves of the vestibule and the vomiting center in the brain by blocking the action of acetylcholine. Methscopolamine bromide also may work directly on the vomiting center. Methscopolamine bromide must be taken before the onset of motion sickness to be effective.

Scopolammonium, N-methylbromide Absorption

Poorly and unreliably absorbed, total absorption is 10-25%.

Scopolammonium, N-methylbromide side effects and Toxicity

Symptoms of a methscopolamine bromide overdose include headache, nausea, vomiting, dry mouth, difficulty swallowing, blurred vision, dilated pupils, hot, dry skin, dizziness; drowsiness, confusion, anxiety, seizures, weak pulse, and an irregular heartbeat. In addition, a curare-like action may occur, i.e., neuromuscular blockade leading to muscular weakness and possible paralysis.

Scopolammonium, N-methylbromide Patient Information

No information avaliable

Scopolammonium, N-methylbromide Organisms Affected

Humans and other mammals